| MeSH term | MeSH ID | Detail |
|---|---|---|
| Nerve Sheath Neoplasms | D018317 | 4 associated lipids |
| HIV Infections | D015658 | 20 associated lipids |
| Leukemia, Myeloid, Acute | D015470 | 19 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Neurilemmoma | D009442 | 10 associated lipids |
| Nephritis | D009393 | 19 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
(e,z)-farnesol
(e,z)-farnesol is a lipid of Prenol Lipids (PR) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 3613 references associated with (e,z)-farnesol in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for (e,z)-farnesol
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (e,z)-farnesol
PubChem Biomolecular Interactions and Pathways
All references with (e,z)-farnesol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chakrabarti D et al. | Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. | 2002 | J. Biol. Chem. | pmid:12194969 |
| Meinhardt G et al. | Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. | 2002 | Anticancer Drugs | pmid:12187329 |
| Du Y and Wiemer DF | Alpha-phosphono lactone analogues of farnesyl pyrophosphate: an asymmetric synthesis via ring-closing metathesis. | 2002 | J. Org. Chem. | pmid:12153272 |
| Akiyama H et al. | Actions of farnesol and xylitol against Staphylococcus aureus. | 2002 | Chemotherapy | pmid:12138327 |
| Raner GM et al. | Farnesol as an inhibitor and substrate for rabbit liver microsomal P450 enzymes. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054554 |
| Lagace TA et al. | Caspase processing and nuclear export of CTP:phosphocholine cytidylyltransferase alpha during farnesol-induced apoptosis. | 2002 | Mol. Cell. Biol. | pmid:12052891 |
| George J et al. | Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice. | 2002 | Circulation | pmid:12021230 |
| Takahashi N et al. | Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. | 2002 | FEBS Lett. | pmid:11943173 |
| Hamada M et al. | Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells. | 2002 | FEBS Lett. | pmid:11943160 |
| Smalley KS and Eisen TG | Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. | 2002 | Int. J. Cancer | pmid:11920610 |
| Teal PE | Effects of allatotropin and allatostatin on in vitro production of juvenile hormones by the corpora allata of virgin females of the moths of Heliothis virescens and Manduca sexta. | 2002 | Peptides | pmid:11897385 |
| Radetich B and Corey EJ | A general stereocontrolled, convergent synthesis of oligoprenols that parallels the biosynthetic pathway. | 2002 | J. Am. Chem. Soc. | pmid:11890779 |
| Gana-Weisz M et al. | The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. | 2002 | Clin. Cancer Res. | pmid:11839677 |
| Katzav A et al. | Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). | 2001 | Clin. Exp. Immunol. | pmid:11737078 |
| Sari R et al. | Impairment by lovastatin of neural relaxation of the rabbit sphincter of Oddi. | 2001 | Eur. J. Pharmacol. | pmid:11734192 |
| Kim SY et al. | Inhibition effect of new farnesol derivatives on all-trans-retinoic acid metabolism. | 2001 | Metab. Clin. Exp. | pmid:11699057 |
| Karussis D et al. | The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis. | 2001 | J. Neuroimmunol. | pmid:11694313 |
| Villegas LF et al. | (+)-epi-Alpha-bisabolol [correction of bisbolol] is the wound-healing principle of Peperomia galioides: investigation of the in vivo wound-healing activity of related terpenoids. | 2001 | J. Nat. Prod. | pmid:11678668 |
| Mizukami Y et al. | Requirement of c-jun N-terminal kinase for apoptotic cell death induced by farnesyltransferase inhibitor, farnesylamine, in human pancreatic cancer cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11594773 |
| Rakhit RD et al. | Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11527399 |